Cingulate Inc. Class of Warrant or Right, Exercise Price of Warrants or Rights
Cingulate Inc. (CING) had Class of Warrant or Right, Exercise Price of Warrants or Rights of $0.00 per share as of 2023-09-08, per its 10-K filed 2024-04-01.
Discontinued › Notes
us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 · last filed 2024-04-01
- 2023-09-08: Class of Warrant or Right, Exercise Price of Warrants or Rights $0.00; Class of Warrant or Right, Exercise Price of Warrants or Rights as first filed $0.00.
| Period end | Class of Warrant or Right, Exercise Price of Warrants or Rights | Class of Warrant or Right, Exercise Price of Warrants or Rights as first filed |
|---|---|---|
| 2023-09-08 | $0.00 10-K · filed 2024-04-01 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |